Inhaled budesonide in neonatal respiratory distress syndrome: is it beneficial?

Phase 1

Completed

• Conditions: neonate , respiratory distress; neonatal respiratory distress

• Registration Number: TCTR20201228003
• Lead Sponsor: mohamed shawky elfarargy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2017-03-07
• Study Start: 2020-12-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

neonates suffering from RDS

Exclusion Criteria

neonatal infections

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
respiratory distress at 5 days after end of the intervention(inhaled budesonide administration) ELISA method for measuring IL-8 in neonate with respiratory distress

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A